U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drugs@FDA

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

New Drug Application (NDA): 021316
Company: AZURITY
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
ALTOPREV LOVASTATIN 10MG TABLET, EXTENDED RELEASE;ORAL Discontinued None No No
ALTOPREV LOVASTATIN 20MG TABLET, EXTENDED RELEASE;ORAL Discontinued None Yes No
ALTOPREV LOVASTATIN 40MG TABLET, EXTENDED RELEASE;ORAL Discontinued None Yes No
ALTOPREV LOVASTATIN 60MG TABLET, EXTENDED RELEASE;ORAL Discontinued None Yes No
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels,
Patient Package Insert
Note Url
03/14/2024 SUPPL-37 Labeling-Package Insert Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/021316s037lbl.pdf
09/25/2020 SUPPL-36 Labeling-Package Insert Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021316s036lbl.pdf
02/28/2018 SUPPL-35 Labeling-Package Insert Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021316s035lbl.pdf
08/04/2017 SUPPL-34 Labeling-Package Insert Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021316s034lbl.pdf
04/30/2014 SUPPL-31 Labeling-Package Insert Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021316s031lbl.pdf
12/21/2012 SUPPL-28 Labeling-Package Insert Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021316s028lbl.pdf
10/31/2012 SUPPL-29 Labeling-Package Insert Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021316s029lbl.pdf
04/26/2012 SUPPL-26 Labeling-Package Insert Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021316s026lbl.pdf
07/21/2004 SUPPL-10 Labeling Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/21316s010lbl.pdf
09/24/2003 SUPPL-6 Labeling Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2003/21316slr006_lovastatin_lbl.pdf
09/11/2002 SUPPL-1 Efficacy-New Indication Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2002/21316s1lbl.pdf
06/26/2002 ORIG-1 Approval Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2002/21316lbl.pdf
Back to Top